LY217896 is a substituted thiadiazole compound with anti-influenza activity in vitro and in the mouse model of infection. LY297336 is a ribosylated (N-4) derivative of LY217896. A highly polar intracellular metabolite of LY217896 was isolated by HPLC, and mass spectral analysis and treatment of the metabolite with alkaline phosphatase showed that it was a monophosphate (LY307987) derived from LY217896. The formation of LY307987 was inhibited by 43 and 63% when 10 μm of LY217896 was incubated with 100 μM of 8-aminoguanosine (8AGuo) and guanine (Gua), respectively, whereas inosine (Ino) and hypoxanthine (Hx) had no effect on the formation of LY307987. LY217896 inhibited the incorporation of [14C]-Hx into nucleic acids in cells which metabolize LY217896; however, LY217896 did not inhibit the formation of inosine 5′-monophosphate (IMP) from Hx in a cell-free HGPRT (hypoxanthine-guanine phosphoribosyltransferase)-catalysed reaction. Incubation of MDCK cells with 10 μm of LY217896 resulted in an 8-fold increase in the level of intracellular IMP. At 100 μm, neither LY217896 nor LY297336 inhibited inosine 5′-monophosphate dehydrogenase (IMPDH) and only cellular extracts which contained intracellular metabolites of LY217896 inhibited IMPDH. Quantification of the 5-phosphorylribose pyrophosphate (PRPP) levels in BS-C-1, MDCK, and MCN cells showed a positive correlation between PRPP concentration and cellular metabolism of LY217896. Combination studies of LY217896 with 2′,3′-dideoxyinosine (ddlno) or 2′,3′-dideoxyguanosine (ddGuo) showed that LY217896 enhanced the antiretroviral activities of these dideoxynucleosides, which is consistent with an inhibitory effect on IMPDH.
AhluwaliaG.CooneyD. A.BondocL. L.Jr.CurrensM. J.FordH.JohnsD. G.MitsuyaH., and FridlandA. (1990) Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2′,3′-dideoxyguanosine. Biochem Biophys Res Comm171: 1297–1303.
2.
AllenL. B.VandersliceL K.FingalC. M.McCrightF. H.HarrisE. F., and CookP. D. (1982) Evaluation of the anti-herpes drug combinations: virazole plus arabinofuranosylhypoxanthine and virazole plus arabinosylfuranosyladenine. Antiviral Res2: 203–216.
3.
ArdalanB.ArakawaM.VillacorteD.JayaramH., and CooneyD. A. (1982) Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo. Biochem Pharmacol31: 1509–1513.
4.
BabaM.PauwelsR.BalzariniJ.HerdewijnP.De ClercqE, and DesmyterJ. (1987) Ribavirin antagonizes inhibitory effects of pyrimidine 2′,3′-dideoxynucleosides but enhances inhibitory effects of purine 2′,3′-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Antimicrob Agents Chemother31: 1613–1617.
5.
BalzariniJ.HerdewijnP., and De ClercqE. (1989) Potentiating effect of ribavirin on the anti-retrovirus activity of 3′-azido-2,6-diaminopurine-2′,3′-dideoxyriboside in vitro and in vivo. Antiviral Res11: 161–172.
6.
BalzariniJ.NaesensL.RobinsM. J., and De ClercqE. (1990) Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2′,3′-dideoxyinosine and 2′,3′-dideoxy-2,6-diaminopurine riboside. J AIDS3: 1140–1147.
7.
BalzariniJ.LeeC.-K.HerdewijnP., and De ClercqE. (1991a) Mechanism of the potentiating effect of ribavirin on the activity of 2′,3′-dideoxyinosine against human immunodificiency virus. J Biol Chem266: 21509–21514.
8.
BalzariniJ.LeeC-KScholsD., and De ClercqE. (1991b) 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (Ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes. Biochem Biophys Res Comm178: 563–569.
9.
ColacinoJ. M.DelongD. C.NelsonJ. R.SpitzerW. A.TangJ.VictorF., and WuC.-Y. E. (1990) Evaluation of the anti-influenza virus activities of 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and its sodium salt. Antimicrob Agents Chemother34: 2156–2163.
10.
ColacinoJ. M.BirchG. M., and TangJ.C. (1993) Cellular metabolism and anti-influenza activity of 1,3,4-thiadiazol-2-ylcyanamide (LY217896). Antiviral Chem and Chemother4: 271–280.
11.
CooneyD A.JayaremH. N.GebeyehuG.BettsC. R.KelleyJ. A.MarquezV. E., and JohnsD. G. (1982) The conversion of tiazofurin to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. Biochem Pharmacol31: 2133–2136.
12.
De ClercqE., and MeriganT. C. (1971) Moloney sarcoma virus-induced tumors in mice: inhibition or stimulation by (poly rl) (poly rC) (35627). Proc Soc Exp Biol Med137: 590–594.
13.
EhlhardtW. J.WheelerW. J.BreauA. P.ChayS. H., and BirchG. M. (1993) Biotransformation of the antiviral agent 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and characteristics of a mesoionic ribose metabolite. Drug Metab Disp21: 162–170.
14.
ElionG. B.SingerS., and HitchingsG. H. (1954) Antagonists of nucleic acid derivatives. VIII. synergism in combinations of biochemically related antimetabolites. J Biol Chem208: 477–488.
15.
FortiR. L.SchuffmanS. S.DaviesH. A., and MitchellW. M. (1986) Objective Antiviral assay of the interferons by computer assisted data collection and analysis. Methods Enzymol119: 533–540.
16.
HartmanN. R.AhluwaliaG. S.CooneyD. A.MitsuyaH.KageyamaS.FridlandA.BroderS., and JohnsD. G. (1991) Inhibitors of IMP dehyrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2′,3′-dideoxyadenosine and 2′,3′-dideoxyinosine. Mol Pharmacol40: 118–124.
17.
HaydenF. G.CoteK. M., and DouglasR. G.Jr. (1980) Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother17: 865–870.
18.
HaydenF. G.RollinsB. S., and HayA. J. (1990) Anti-influenza virus activity of the compound LY253963. Antiviral Res14: 25–38.
19.
HendersonJ. F., and PattersonA. R. P. (1973) Nucleoside Metabolism: An Introduction. Academic Press, New York.
20.
HodgesS. D.FungE.McKayD. J.RenauxB. S., and SnyderF. F. (1989) Increased activity, amount, and altered kinetic properties of IMP dehydrogenase from mycophenolic acid-resistant neuroblastoma cells. J Biol Chem264: 18137–18141.
21.
JohnsonM. A., and FridlandA. (1989) Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol Pharmacol36: 291–295.
22.
KongC. M., and ParksR. E.Jr (1974) Human erythrocytic hypoxanthine-guanine phosphoribosyltransferase: effect of pH on the enzymatic reaction. Mol Pharmacol10: 648–656.
23.
LeeH.-J.PawlakK.NguyenB. T.RobinsR. K., and SadeeW. (1985) Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture. Cancer Res45: 5512–5520.
24.
MalinoskiF., and StollarV. (1981) Inhibitors of IMP dehydrogenase prevent Sindbis virus replication and reduce GTP levels in Aedes albopictus cells. Virology110: 281–291.
25.
NelsonJ. A.RoseL. M., and BennetL. L. (1976) Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells. Cancer Res36: 1375–1378.
26.
NelsonJ. A.RoseL. M., and BennetL. L. (1977) Mechanism of action of 2-amino-1,3,4-thiadiazole (NSC 4728). Cancer Res37: 182–187.
27.
RobinsR. K.SrivastavaP. C.NarayananV. L.PlowmanJ., and PaullK. (1982) D. 2-β-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases. J Med Chem25: 107–108.
28.
SnyderF. F.MendelsohnJ., and SeegmillerJ. E. (1976) Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes. J Clin Invest58: 654–666.
29.
StoecklerJ. D.CamborC.KuhnsV.ChuS.-H., and ParksR. E.Jr. (1982) Inhibitors of Purine Nucleoside Phosphorylase C(8) and C(5′) Substitutions. Biochem Pharmacol31: 163–172.
30.
StreeterD. G.WitkowskiJ.T.KhareG. P.SidwellR. W.BauerR. J.RobinsR. K., and SimonL. N. (1973) Mechanism of Action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad spectrum antiviral agent. Proc Natl Acad Sci USA70: 1174–1178.
31.
VictorF.SpitzerW. A.NelsonJ. D.TangJ.JonesN. D.SwartzendruberJ. K.DeeterJ. B., and BlanchardW. B. (1989) The synthesis and antiviral activity of LY214624. Abstract, ACS Meeting, Miami Beach, FL.
32.
VitkauskasG., and CanellakisE. S. (1984) The regulation of hypoxanthine guanine phosphoribosyl transferase activity through transfer of PRPP by metabolic cooperation. Exp Cell Res152: 541–551.
33.
WheelerW. J., and BlanchardW. B. (1992) The synthesis of 1,3,4-thiadiazol-2-ylcyanamide sodium, a potentially useful anti-influenza agent, and its [5-14C] and [UL-13C3] iso-topomers. J Labelled Cmpd Radiopharm31: 495–504.
34.
WillisR. C.CarsonD. A., and SeegmillerJ. E. (1978) Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line. Proc Natl Acad Sci USA75: 3042–3044.
35.
WrayS. K.GilbertB. E.NoallM. W., and KnightV. (1985) Mode of Action of ribavirìn: Effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Res5: 29–37.
36.
WydeP. R.AmbroseM. W.MeyerH. L., and GilbertB. E. (1990) Toxicity and antiviral activity of LY253963 against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats. Antiviral Res14: 237–248.
